@article {de la Fuente2021.05.06.21256747, author = {Javier de la Fuente and Andrew D. Grotzinger and Riccardo E. Marioni and Michel G. Nivard and Elliot M. Tucker-Drob}, title = {Multivariate Modeling of Direct and Proxy GWAS Indicates Substantial Common Variant Heritability of Alzheimer{\textquoteright}s Disease}, elocation-id = {2021.05.06.21256747}, year = {2021}, doi = {10.1101/2021.05.06.21256747}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Genome-wide association studies (GWAS) of proxy-phenotypes using family history of disease (GWAX) substantially boost power for genetic discovery when combined with direct case-control GWAS, most prominently in the context of Alzheimer{\textquoteright}s Disease (AD). However, despite twin study heritability estimates of approximately 60\%, recent SNP-based estimates of common variant heritability of AD from meta-analyzed GWAS-GWAX data have been particularly low (2.5\%), calling into question the prospects of continued progress in AD genetics. We demonstrate that commonly used approaches for combining GWAX and GWAS data produce dramatic underestimates of heritability, and we introduce a multivariate method for estimating individual SNP effects and recovering unbiased estimates of SNP heritability when combining GWAS and GWAX summary data. We estimate the SNP heritability of Clinical AD diagnoses excluding the APOE region at \~{}6-10\%, with the corresponding estimate for biological AD (based on prevalence rate estimates from recently published molecular imaging data) as high as \~{}20\%. Common variant risk for AD appears to represent a very strong effect of APOE superimposed upon a relatively diffuse polygenic signal that is distributed across the genome.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNot human subject researchFunding StatementThis work presented here would not have been possible without the enormous efforts put forth by the investigators and participants from the International Genomics of Alzheimer{\textquoteright}s Project (IGAP) and the UK Biobank. The work from these contributing groups was supported by numerous grants from governmental and charitable bodies. Research reported in this publication was supported by the National Institutes of Health (NIH) grant R01AG054628. J.F. and E.M.T-D. are members of the Population Research Center (PRC) and Center on Aging and Population Sciences (CAPS) at The University of Texas at Austin, which are supported by National Institutes of Health (NIH) grants P2CHD042849 and P30AG066614, respectively. R.E.M. was supported by Alzheimer{\textquoteright}s Research UK major project grant ARUK-PG2017B-10.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We have used de-identified GWAS summary statistics for the analyses reported in the current study. For those no IRB oversight is necessary. Summary statistics used in the present analyses are publicly available for download using the database links noted in the manuscript.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are all publicly available or can be requested for access. Specific download links for various datasets are directly below. Summary statistics for IGAP are available from: https://www.niagads.org/datasets/ng00075 Summary statistics for UK Biobank can be downloaded from: https://www.ccace.ed.ac.uk/node/335 https://www.niagads.org/datasets/ng00075 https://www.ccace.ed.ac.uk/node/335}, URL = {https://www.medrxiv.org/content/early/2021/05/10/2021.05.06.21256747}, eprint = {https://www.medrxiv.org/content/early/2021/05/10/2021.05.06.21256747.full.pdf}, journal = {medRxiv} }